The new company, ProvideGx, will allow Premier to invest in new business models and partnerships to address drug shortages. The company plans to work with generic drug manufacturers, co-fund development of affordable products and secure contracts for active pharmaceutical ingredients to ensure supply demands are met.
ProvideGx already has partnered with five generic manufacturers to mitigate shortages and sidestep the price hikes of 60 crucial drugs.
The new company will begin marketing more l products in short supply next month, pending FDA approval.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.